These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35382974)

  • 41. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
    PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emricasan (IDN-6556) Lowers Portal Pressure in Patients With Compensated Cirrhosis and Severe Portal Hypertension.
    Garcia-Tsao G; Fuchs M; Shiffman M; Borg BB; Pyrsopoulos N; Shetty K; Gallegos-Orozco JF; Reddy KR; Feyssa E; Chan JL; Yamashita M; Robinson JM; Spada AP; Hagerty DT; Bosch J
    Hepatology; 2019 Feb; 69(2):717-728. PubMed ID: 30063802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery.
    Reverter E; Cirera I; Albillos A; Debernardi-Venon W; Abraldes JG; Llop E; Flores A; Martínez-Palli G; Blasi A; Martínez J; Turon F; García-Valdecasas JC; Berzigotti A; de Lacy AM; Fuster J; Hernández-Gea V; Bosch J; García-Pagán JC
    J Hepatol; 2019 Nov; 71(5):942-950. PubMed ID: 31330170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
    Talakić E; Schaffellner S; Kniepeiss D; Mueller H; Stauber R; Quehenberger F; Schoellnast H
    Eur Radiol; 2017 Oct; 27(10):4173-4180. PubMed ID: 28321540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of HIV-1 Infection on Angiopoietin 1 and 2 Levels and Measures of Microvascular and Macrovascular Endothelial Dysfunction.
    Thakkar AB; Ma Y; Dela Cruz M; Wu Y; Arechiga V; Swaminathan S; Ganz P; Wu AHB; Scherzer R; Deeks S; Hsue PY
    J Am Heart Assoc; 2021 Nov; 10(22):e021397. PubMed ID: 34726064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.
    Pinter M; Sieghart W; Reiberger T; Rohr-Udilova N; Ferlitsch A; Peck-Radosavljevic M
    Aliment Pharmacol Ther; 2012 Jan; 35(1):83-91. PubMed ID: 22032637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia.
    Mandriota SJ; Pepper MS
    Circ Res; 1998 Oct; 83(8):852-9. PubMed ID: 9776732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis.
    Wang T; Liang F; Zhou Z; Shi L
    J Biomech; 2017 Dec; 65():23-31. PubMed ID: 29042056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Study on the correlation between PPG and HVPG in patients with portal hypertension].
    Wang L; Song QK; Yue ZD; Zhao HW; Fan ZH; Wu YF; Liu FQ; Meng K; Zhang L; Jiang HG; Ding YN; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):722-727. PubMed ID: 36038341
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatic venous pressure gradient determination in patients with hepatitis C virus-related and alcoholic cirrhosis.
    Bellis L; Castellacci R; Montagnese F; Festuccia F; Corvisieri P; Puoti C
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1085-9. PubMed ID: 14501616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.
    Mandorfer M; Schwabl P; Paternostro R; Pomej K; Bauer D; Thaler J; Ay C; Quehenberger P; Fritzer-Szekeres M; Peck-Radosavljevic M; Trauner M; Reiberger T; Ferlitsch A;
    Aliment Pharmacol Ther; 2018 Apr; 47(7):980-988. PubMed ID: 29377193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease.
    Gharib AM; Han MAT; Meissner EG; Kleiner DE; Zhao X; McLaughlin M; Matthews L; Rizvi B; Abd-Elmoniem KZ; Sinkus R; Levy E; Koh C; Myers RP; Subramanian GM; Kottilil S; Heller T; Kovacs JA; Morse CG
    Biomed Res Int; 2017; 2017():2067479. PubMed ID: 28480218
    [No Abstract]   [Full Text] [Related]  

  • 54. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
    Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
    World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation.
    Calvaruso V; Dhillon AP; Tsochatzis E; Manousou P; Grillo F; Germani G; Patch D; O'Beirne J; Burroughs AK
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1227-32. PubMed ID: 22432427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
    Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
    Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis.
    Virseda-Berdices A; Brochado-Kith O; Díez C; Hontañon V; Berenguer J; González-García J; Rojo D; Fernández-Rodríguez A; Ibañez-Samaniego L; Llop-Herrera E; Olveira A; Perez-Latorre L; Barbas C; Rava M; Resino S; Jiménez-Sousa MA
    J Antimicrob Chemother; 2022 Feb; 77(3):719-726. PubMed ID: 34888660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
    Simbrunner B; Marculescu R; Scheiner B; Schwabl P; Bucsics T; Stadlmann A; Bauer DJM; Paternostro R; Eigenbauer E; Pinter M; Stättermayer AF; Trauner M; Mandorfer M; Reiberger T
    Liver Int; 2020 Jul; 40(7):1713-1724. PubMed ID: 32358998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.
    Ebrahimi F; Semela D; Heim M
    Hepatol Int; 2022 Aug; 16(4):817-823. PubMed ID: 34699037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems.
    Hernández-Bartolomé Á; López-Rodríguez R; García-Buey L; Martín-Vílchez S; Rodríguez-Muñoz Y; Borque MJ; González-Moreno L; Real-Martínez Y; Mendoza-Ridruejo J; Martín-Pérez E; Moreno-Otero R; Sanz-Cameno P
    Liver Int; 2017 Aug; 37(8):1148-1156. PubMed ID: 28027429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.